These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2834823)

  • 1. Obstacles to an AIDS vaccine.
    Barnes DM
    Science; 1988 May; 240(4853):719-21. PubMed ID: 2834823
    [No Abstract]   [Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120.
    Berman PW; Groopman JE; Gregory T; Clapham PR; Weiss RA; Ferriani R; Riddle L; Shimasaki C; Lucas C; Lasky LA
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5200-4. PubMed ID: 2455898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Part of AIDS virus is patented.
    Sun M
    Science; 1988 Feb; 239(4843):970. PubMed ID: 2830668
    [No Abstract]   [Full Text] [Related]  

  • 4. [A potential AIDS vaccine tester].
    Fortschr Med; 1988 Jul; 106(22):14-5. PubMed ID: 2851511
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccines and immunology. Overview.
    Laurence J
    AIDS; 1988; 2 Suppl 1():S91-4. PubMed ID: 2852505
    [No Abstract]   [Full Text] [Related]  

  • 6. Second AIDS trial.
    Ezzell C
    Nature; 1988 Jan; 331(6154):290. PubMed ID: 2829025
    [No Abstract]   [Full Text] [Related]  

  • 7. Harming and protecting responses to HIV.
    Lanzavecchia A
    Res Immunol; 1989 Jan; 140(1):99-103; discussion 123-4. PubMed ID: 2567046
    [No Abstract]   [Full Text] [Related]  

  • 8. Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men.
    Krohn K; Robey WG; Putney S; Arthur L; Nara P; Fischinger P; Gallo RC; Wong-Staal F; Ranki A
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4994-8. PubMed ID: 2440037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine.
    Arthur LO; Pyle SW; Nara PL; Bess JW; Gonda MA; Kelliher JC; Gilden RV; Robey WG; Bolognesi DP; Gallo RC
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8583-7. PubMed ID: 3479807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack.
    Lyerly HK; Matthews TJ; Langlois AJ; Bolognesi DP; Weinhold KJ
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4601-5. PubMed ID: 3037522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans.
    Berzofsky JA; Bensussan A; Cease KB; Bourge JF; Cheynier R; Lurhuma Z; Salaün JJ; Gallo RC; Shearer GM; Zagury D
    Nature; 1988 Aug; 334(6184):706-8. PubMed ID: 2457809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus gp120 glycoprotein detected by a monoclonal antibody to a synthetic peptide.
    Chanh TC; Kennedy RC; Alderete BE; Kanda P; Eichberg JW; Dreesman GR
    Eur J Immunol; 1986 Nov; 16(11):1465-8. PubMed ID: 3023102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD4 antigen: physiological ligand and HIV receptor.
    Sattentau QJ; Weiss RA
    Cell; 1988 Mar; 52(5):631-3. PubMed ID: 2830988
    [No Abstract]   [Full Text] [Related]  

  • 14. Antigenic structures recognized by T cells: towards the rational design of an AIDS vaccine.
    Cease KB; Berzofsky JA
    AIDS; 1988; 2 Suppl 1():S95-101. PubMed ID: 3147685
    [No Abstract]   [Full Text] [Related]  

  • 15. Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus.
    Schneider J; Kaaden O; Copeland TD; Oroszlan S; Hunsmann G
    J Gen Virol; 1986 Nov; 67 ( Pt 11)():2533-8. PubMed ID: 2431105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS vaccine.
    Minn Med; 1991 Jan; 74(1):41. PubMed ID: 2002792
    [No Abstract]   [Full Text] [Related]  

  • 17. AIDS vaccines: back to 'plan A'.
    Check E
    Nature; 2003 Jun; 423(6943):912-4. PubMed ID: 12827164
    [No Abstract]   [Full Text] [Related]  

  • 18. Proliferative T-cell response to HIV envelope glycoprotein in immunized and infected primates and human beings.
    Krohn K; Ranki A; Lusso P; Moss B; Ashorn P; Arthur LO; Putney SD; Gallo RC
    J Med Primatol; 1989; 18(3-4):363-9. PubMed ID: 2547967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can an AIDS vaccine be developed?
    Levy JA
    Transfus Med Rev; 1988 Dec; 2(4):264-71. PubMed ID: 2856529
    [No Abstract]   [Full Text] [Related]  

  • 20. Human trials of experimental AIDS vaccines: recombinant envelope proteins.
    Snart RS
    AIDS; 1988; 2 Suppl 1():S107-11. PubMed ID: 2906544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.